Calyx (CEO David Herron) participated in ‘BIO KOREA 5 (Bio Korea 10)’ held at COEX in Seoul for 12 days from Wednesday, May 3th to Friday, May 2023th.
Calyx is a leading global e-Clinical and regulatory solutions company that helps customers bring new treatments to market quickly and reliably. The company emphasized that it is solving complex clinical development and regulatory challenges by combining pioneering technology and expert personnel with expertise based on more than 30 years of experience.
Calyx’s proven suite of solutions has supported more than 650 approvals to date, including medical imaging, IRT (RTSM), Regulatory Information Management (RIM), Clinical Trial Management (CTMS), and Electronic Data Capture (EDC). ) is included.
Among these, Calyx IRT (formerly ClinPhone) is the industry’s best randomization and investigational drug supply management system and is said to have proven its excellence in meeting complex trial requirements, minimizing risk, and optimizing supply. This ensures that sponsors and CROs meet key milestones for the assignment.
According to the ‘2020 ISR RTSM Report’, Calyx IRT is known to be the most used and preferred solution worldwide. Major global sponsors have received help from Calyx IRT to quickly and reliably bring new treatments to the market.
In addition, medical imaging services are provided by a large and diverse team of professional scientists. With experience from 2,600 studies, we design and implement an imaging strategy tailored to your goals, whether you are in early development seeking a partner, planning regulatory approval, or seeking breakthrough therapy designation. .
Globally, Calyx’s medical imaging has supported 235 regulatory approvals, and in Korea, it has supported 22 studies for major biopharmaceutical companies as well as bio ventures.
Rather than rest on our laurels, Calyx continues to develop innovative technologies to improve clinical trial and regulatory efficiency. Recently, it collaborated with Microsoft to provide a cloud-based solution. By moving from an on-premises solution to Microsoft Azure native technology, Calyx CTMS and Calyx RIM users can upgrade quickly. They can also take advantage of new features that can increase efficiency and minimize disruption to business processes, while keeping research on track and ensuring patient safety, officials explained.
“We are integrating Microsoft Azure into everything we do,” the official said. “Calyx’s development plans include expanding our medical imaging capabilities to a broader range of digital biomarker services,” he said. “The future of clinical development lies in understanding how technology can help identify changes in patient symptoms more quickly. “I think that’s the core of it.”
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. it went on